Reproductive · PANCE / PANRE

Placental Abruption

Premature separation of the normally implanted placenta — painful bleeding with uterine hypertonus and fetal distress.

Also known as: placental abruption, abruptio placentae, concealed abruption

Overview

Premature separation of the normally implanted placenta from the decidua basalis before delivery of the fetus. May be partial or complete, revealed (vaginal bleeding) or concealed (retroplacental hemorrhage without external bleeding).

Epidemiology

Affects ~0.5-1% of pregnancies. Leading cause of antepartum hemorrhage along with placenta previa. Major cause of perinatal mortality.

🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Placental Abruption outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Hypertensive disorders (chronic HTN, preeclampsia) — strongest modifiable risk factor
  • Prior abruption (10-15% recurrence)
  • Cocaine, methamphetamine use
  • Smoking
  • Trauma (motor vehicle accident, fall, intimate partner violence) — even minor
  • Rapid uterine decompression (rupture of membranes with polyhydramnios, delivery of first twin)
  • Premature rupture of membranes, chorioamnionitis
  • Advanced maternal age, multiparity
  • Thrombophilia

Pathophysiology

Vascular disruption at the decidual-placental interface produces a retroplacental hematoma that expands and dissects further placental separation. Concealed hemorrhage with hematoma can extravasate into myometrium (Couvelaire uterus). Thromboplastin release into maternal circulation activates the coagulation cascade → DIC (occurs in up to 20% of severe abruptions).

Clinical presentation

Symptoms

  • Sudden onset abdominal/back pain
  • Vaginal bleeding (dark red; absent in ~20% — concealed abruption)
  • Uterine contractions or hypertonus
  • Decreased fetal movement
  • Symptoms of hypovolemia: dizziness, syncope

Signs / physical exam

  • Firm, tender, hypertonic uterus (board-like)
  • Frequent contractions, tachysystole
  • Nonreassuring fetal heart tones (late decelerations, bradycardia, loss of variability)
  • Hypotension, tachycardia (out of proportion to visible bleeding — concealed)
  • DIC findings: oozing from IV sites, hematuria, abnormal coagulation

Classic findings

Third-trimester woman with painful dark vaginal bleeding, firm tender uterus, and nonreassuring fetal heart tones — especially in setting of hypertension or trauma.

Differential diagnosis

  • Placenta previa — Painless bright red bleeding, soft uterus
  • Uterine rupture — Severe pain, loss of fetal station, fetal bradycardia; usually with prior uterine surgery
  • Vasa previa — Fetal vessels rupture with membrane rupture; fetal blood loss
  • Preterm labor — Regular contractions with cervical change; bleeding may be present (bloody show)
  • Chorioamnionitis — Fever, uterine tenderness, fetal tachycardia; PROM history
  • Trauma without abruption — Trauma can cause abruption hours later; observe with continuous monitoring 4-24 hours

Diagnostic workup

Labs

  • CBC, blood type and crossmatch
  • Coagulation studies (PT, PTT, fibrinogen — pregnancy normal >300-400 mg/dL; <200 concerning, <150 critical)
  • DIC panel: fibrinogen, D-dimer, FDP, platelets
  • BMP, LFTs
  • Kleihauer-Betke for fetomaternal hemorrhage and dosing of anti-D
  • Urinalysis (toxicology if substance use suspected)

Imaging

  • Continuous external fetal monitoring — most important assessment
  • Tocodynamometry — high-frequency low-amplitude contractions or hypertonus
  • Ultrasound — retroplacental hematoma visible in only ~25-50% of cases; absence does NOT rule out abruption
  • Placental abruption is primarily a CLINICAL diagnosis

Diagnostic algorithm

flowchart TD
  A[Third-trimester bleeding<br/>± pain] --> B[Avoid digital exam<br/>until previa excluded]
  B --> C[Ultrasound +<br/>continuous fetal monitoring<br/>+ labs incl coags]
  C --> D{Diagnosis?}
  D -->|Previa on US| E[Manage as previa]
  D -->|Abruption suspected<br/>clinical| F[Hemodynamic status?]
  F -->|Unstable or<br/>nonreassuring FHR| G[Emergent cesarean<br/>+ resuscitation<br/>+ blood products]
  F -->|Stable, reassuring| H{Gestational age}
  H -->|≥36 weeks| I[Deliver — vaginal<br/>if labor progressing]
  H -->|<36 weeks| J[Hospitalize, corticosteroids,<br/>close monitoring]
  J --> K{Worsening?}
  K -->|Yes| G
  K -->|No| L[Deliver at 36-37 weeks<br/>or sooner if change]
Algorithm for suspected placental abruption — clinical diagnosis, fetal status drives timing.

Treatment

First-line

  • ABCs — large-bore IV access, type and crossmatch (4-6 units), IV crystalloid resuscitation
  • Continuous fetal monitoring
  • Left lateral decubitus positioning, oxygen
  • Foley catheter — strict input/output
  • Lab studies including coagulation
  • Anti-D immunoglobulin for Rh-negative women

Severe abruption / fetal distress

  • Emergent cesarean delivery (unless vaginal delivery imminent and stable)
  • Aggressive resuscitation; blood product transfusion (PRBCs, FFP, platelets, cryoprecipitate per protocol)
  • Massive transfusion protocol if needed
  • Treat DIC with blood products targeting fibrinogen >200 mg/dL
  • Postpartum monitoring for atony, DIC, AKI

Mild abruption with reassuring fetal status

  • Hospitalize for continuous monitoring
  • Antenatal corticosteroids if 23-34 weeks
  • If preterm and stable, expectant management with close monitoring
  • Deliver if 36+ weeks, worsening clinical status, or nonreassuring fetal heart tones

Fetal demise

  • Vaginal delivery often preferred if maternally stable to avoid surgical morbidity in coagulopathic patient
  • Cesarean if maternal compromise or labor not progressing
  • Aggressive supportive care; DIC management

Complications

  • Maternal: hypovolemic shock, DIC, acute kidney injury, Couvelaire uterus, postpartum hemorrhage, hysterectomy, Sheehan syndrome, death
  • Fetal: hypoxia, IUGR (chronic abruption), preterm birth, stillbirth (~12% perinatal mortality with significant abruption)
  • Neonatal: birth asphyxia, anemia
  • Recurrence in subsequent pregnancies (~10-15%)

PANCE pearls

  • Placental abruption is a CLINICAL diagnosis — ultrasound has low sensitivity (~25-50%); negative imaging does NOT rule it out.
  • Concealed abruption can present with disproportionate maternal hemodynamic compromise relative to visible bleeding; suspect when hypotension exceeds expected blood loss.
  • All pregnant trauma patients require ≥4 hours of continuous fetal monitoring (24 hours if abnormal); abruption can present hours after the initial event.
  • DIC complicates ~10-20% of severe abruptions; fibrinogen levels are the best marker — pregnant women normally have elevated fibrinogen, so a 'normal' value of 200 may already represent significant consumption.
  • Couvelaire uterus (uterine apoplexy with bluish discoloration from blood extravasation into myometrium) does not necessarily require hysterectomy — manage based on hemostasis.
  • Cocaine and methamphetamine use cause vasoconstriction-mediated abruption — assess for substance use in unexplained abruptions.
  • Painful dark bleeding with tense tender uterus = abruption; painless bright red bleeding with soft uterus = previa.

References

  • ACOG PB 234 — ACOG Practice Bulletin No. 234: Prediction and Prevention of Spontaneous Preterm Birth (related guidance)
  • ACOG CO 518 — ACOG Committee Opinion 518: Intimate Partner Violence (relevant trauma risk)
  • Ananth 2006 — Placental Abruption and Adverse Perinatal Outcomes (Ananth and Wilcox, Am J Epidemiol 2006)

Practice Reproductive questions on FirstPassPA

Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start studying free → Browse all 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.